Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07398404 · ClinicalTrials.gov registry record · Phase 1
A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients
A Phase 1 study, sponsored by Medical University of South Carolina.
- Not yet
- Registry status
- Phase 1
- Development phase
- 64
- Enrollment target
NCT07398404: Clinical Trial Phase 1 study, sponsored by Medical University of South Carolina.
NCT07398404 is a Phase 1 study that has not yet begun recruiting, run by Medical University of South Carolina. The registered enrollment target is 64 participants, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07398404, a Phase 1 study, has not yet begun recruiting, sponsored by Medical University of South Carolina.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 64 participants
- Enrollment target
Study Summary
The purpose of this research study is to evaluate a multiple health behavior change intervention for weight loss and smoking cessation using medication (Naltrexone + Bupropion) and behavior therapy in adults seeking bariatric surgery. The intervention will be compared to a standard of care control group.
Primary Outcome
Number of participants enrolled out of participants screened.
Interventions
- BEHAVIORAL Cognitive-Behavioral Therapy
- DRUG Bupropion Hydrochloride Extended-release
- DRUG Naltrexone hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2026-09-01 |
| Est. Completion | 2031-06-30 |
| Phase | Phase 1 |
What is known before NCT07398404 opens enrollment
NCT07398404 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target.
The record links to 0 conditions, and to 3 interventions - of which Cognitive-Behavioral Therapy is the first listed.
NCT07398404 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07398404 about?
NCT07398404 is a clinical study titled "A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients". The purpose of this research study is to evaluate a multiple health behavior change intervention for weight loss and smoking cessation using medication (Naltrexone + Bupropion) and behavior therapy in adults seeking bariatric surgery. The intervention will be compared to a standard of care control g...
What is the current status of trial NCT07398404?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 64 participants. The study started on 2026-09-01. Estimated completion is 2031-06-30.
What interventions are being tested in trial NCT07398404?
The interventions under investigation include: Cognitive-Behavioral Therapy (BEHAVIORAL), Bupropion Hydrochloride Extended-release (DRUG), Naltrexone hydrochloride (DRUG).
Who is sponsoring clinical trial NCT07398404?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07398404's enrollment target sits among peer trials
64 808th of 2000 higher than 1,181 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI